Neptune Technologies & Bioressources Inc (TSE:NEPT) Director Richard Paul Schottenfeld sold 291,115 shares of the company’s stock in a transaction that occurred on Thursday, September 20th. The stock was sold at an average price of C$4.66, for a total value of C$1,356,595.90.

Shares of NEPT traded down C$0.70 during mid-day trading on Friday, hitting C$5.42. The company’s stock had a trading volume of 895,184 shares, compared to its average volume of 305,216. Neptune Technologies & Bioressources Inc has a one year low of C$0.86 and a one year high of C$6.64.

Neptune Technologies & Bioressources Company Profile

Neptune Technologies & Bioressources Inc, a nutrition products company, produces and commercializes nutraceutical products and turnkey solutions primarily for omega-3 softgel capsules and liquids. It offers specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils, as well as pet supplements.

Featured Story: Stop Order

Insider Buying and Selling by Quarter for Neptune Technologies & Bioressources (TSE:NEPT)

Receive News & Ratings for Neptune Technologies & Bioressources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioressources and related companies with MarketBeat.com's FREE daily email newsletter.